Servier Bets $450M On Kaerus’ Fragile X Syndrome Therapy

KER-0193 is a modulator of ion channels connected to autism spectrum disorder. The FDA bestowed orphan drug and rare pediatric drug designations on the candidate earlier this year.

Scroll to Top